These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8080817)

  • 1. Recombinant toxins.
    Kreitman RJ; Pastan I
    Adv Pharmacol; 1994; 28():193-219. PubMed ID: 8080817
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunotoxins and recombinant toxins for cancer treatment.
    Pai LH; Pastan I
    Important Adv Oncol; 1994; ():3-19. PubMed ID: 8206493
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials of targeted toxins.
    Frankel AE; Tagge EP; Willingham MC
    Semin Cancer Biol; 1995 Oct; 6(5):307-17. PubMed ID: 8562908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting growth factor receptors with fusion toxins.
    Kreitman RJ; FitzGerald D; Pastan I
    Int J Immunopharmacol; 1992 Apr; 14(3):465-72. PubMed ID: 1319965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo studies with chimeric toxins. Interleukin-2 fusion toxins as immunosuppressive agents.
    Shapiro ME; Kirkman RL; Kelley VR; Bacha P; Nichols JC; Strom TB
    Targeted Diagn Ther; 1992; 7():383-93. PubMed ID: 1633300
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapy of cancer with recombinant immunotoxins.
    Pastan I
    Biochim Biophys Acta; 1997 Oct; 1333(2):C1-6. PubMed ID: 9395287
    [No Abstract]   [Full Text] [Related]  

  • 7. Pseudomonas exotoxin: recombinant conjugates as therapeutic agents.
    FitzGerald DJ; Pastan I
    Biochem Soc Trans; 1992 Nov; 20(4):731-4. PubMed ID: 1487051
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted inhibition of tumour cell growth by a bispecific single-chain toxin containing an antibody domain and TGF alpha.
    Schmidt M; Wels W
    Br J Cancer; 1996 Sep; 74(6):853-62. PubMed ID: 8826849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant fusion toxins--a new class of targeted biologic therapeutics.
    Woodworth TG; Nichols JC
    Cancer Treat Res; 1993; 68():145-60. PubMed ID: 8105849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol-modified chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin.
    Wang QC; Pai LH; Debinski W; FitzGerald DJ; Pastan I
    Cancer Res; 1993 Oct; 53(19):4588-94. PubMed ID: 8402632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.
    Theuer CP; FitzGerald DJ; Pastan I
    J Urol; 1993 Jun; 149(6):1626-32. PubMed ID: 8501821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotoxins and recombinant toxins in the treatment of solid carcinomas.
    Theuer CP; Pastan I
    Am J Surg; 1993 Sep; 166(3):284-8. PubMed ID: 8368439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotoxins in cancer therapy.
    Kreitman RJ
    Curr Opin Immunol; 1999 Oct; 11(5):570-8. PubMed ID: 10508704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.
    Kreitman RJ
    BioDrugs; 2009; 23(1):1-13. PubMed ID: 19344187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant toxins for cancer treatment.
    Pastan I; FitzGerald D
    Science; 1991 Nov; 254(5035):1173-7. PubMed ID: 1683495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted toxins in brain tumor therapy.
    Li YM; Hall WA
    Toxins (Basel); 2010 Nov; 2(11):2645-62. PubMed ID: 22069569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-2 receptor: a target for immunotherapy.
    Waldmann TA; Goldman C; Top L; Grant A; Burton J; Bamford R; Roessler E; Horak I; Zaknoen S; Kasten-Sportes C
    Adv Exp Med Biol; 1992; 323():57-66. PubMed ID: 1485565
    [No Abstract]   [Full Text] [Related]  

  • 18. Pseudomonas Exotoxin A Based Toxins Targeting Epidermal Growth Factor Receptor for the Treatment of Prostate Cancer.
    Fischer A; Wolf I; Fuchs H; Masilamani AP; Wolf P
    Toxins (Basel); 2020 Nov; 12(12):. PubMed ID: 33260619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant immunotoxins: new therapeutic agents for cancer treatment.
    Pastan IH
    Cancer Detect Prev; 1993; 17(2):289-93. PubMed ID: 8402714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo.
    Azemar M; Schmidt M; Arlt F; Kennel P; Brandt B; Papadimitriou A; Groner B; Wels W
    Int J Cancer; 2000 Apr; 86(2):269-75. PubMed ID: 10738256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.